Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study.
Jeffrey A. Sosman , Michael A. Davies , Keith T. Flaherty , Douglas B. Johnson
Oncologist
2021
Optimizing the Sequence of Anti-EGFR–Targeted Therapy in EGFR-Mutant Lung Cancer
Catherine B. Meador , Hailing Jin , Elisa de Stanchina , Caroline A. Nebhan
Molecular Cancer Therapeutics 14 ( 2) 542 -552
24
2015
Vasodilator-stimulated Phosphoprotein (VASP) Induces Actin Assembly in Dendritic Spines to Promote Their Development and Potentiate Synaptic Strength
Wan-Hsin Lin , Caroline A. Nebhan , Bridget R. Anderson , Donna J. Webb
Journal of Biological Chemistry 285 ( 46) 36010 -36020
30
2010
Predictive biomarkers of response to immune checkpoint inhibitors in melanoma.
Caroline A. Nebhan , Douglas B. Johnson
Expert Review of Anticancer Therapy 20 ( 2) 137 -145
3
2020
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
Carly Bess Williams , Caroline A. Nebhan , Jinming Yang , Lauren S. Starnes
Breast Cancer Research and Treatment 184 ( 2) 357 -364
2
2020
N-WASP and the Arp2/3 Complex Are Critical Regulators of Actin in the Development of Dendritic Spines and Synapses
Adam M. Wegner , Caroline A. Nebhan , Lan Hu , Devi Majumdar
Journal of Biological Chemistry 283 ( 23) 15912 -15920
179
2008
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.
Ken Takezawa , Valentina Pirazzoli , Maria E. Arcila , Caroline A. Nebhan
Cancer Discovery 2 ( 10) 922 -933
705
2012
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
Darren A.E. Cross , Susan E. Ashton , Serban Ghiorghiu , Cath Eberlein
Cancer Discovery 4 ( 9) 1046 -1061
1,057
2014
MEK inhibitors in non-V600 BRAF mutations and fusions.
Douglas B. Johnson , Caroline A. Nebhan , Marcus S. Noel
Oncotarget 11 ( 44) 3900 -3903
1
2020
An APPL1/Akt signaling complex regulates dendritic spine and synapse formation in hippocampal neurons
Devi Majumdar , Caroline A. Nebhan , Lan Hu , Bridget Anderson
Molecular and Cellular Neuroscience 46 ( 3) 633 -644
42
2011
Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition
Rebecca L. Shattuck-Brandt , Sheau-Chiann Chen , Emily Murray , Christopher Andrew Johnson
Clinical Cancer Research 26 ( 14) 3803 -3818
7
2020
Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma
Caroline Amalia Nebhan
2014
Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety
Douglas B Johnson , Caroline A Nebhan
Expert Review of Anticancer Therapy 1 -8
2021
Immune-checkpoint inhibitors: long-term implications of toxicity
Douglas B Johnson , Caroline A Nebhan , Javid J Moslehi , Justin M Balko
Nature Reviews Clinical Oncology 19 ( 4) 254 -267
118
2022
Clinical models to define response and survival with anti--PD-1 antibodies alone or combined with ipilimumab in metastatic melanoma
Inês Pires da Silva , Tasnia Ahmed , Jennifer L McQuade , Caroline A Nebhan
Journal of Clinical Oncology 40 ( 10) 1068 -1080
16
2022
Clinical activity of mitogen-activated protein kinase--targeted therapies in patients with non--V600 BRAF-mutant tumors
Matthew Dankner , Yifan Wang , Rouhi Fazelzad , Benny Johnson
JCO Precision Oncology 6 e2200107
3
2022
Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a multicenter international cohort study
Caroline A Nebhan , Alessio Cortellini , Weijie Ma , Teja Ganta
JAMA oncology 7 ( 12) 1856 -1861
37
2021
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States
Kathryn Lurain , Talal El Zarif , Ramya Ramaswami , Amin H Nassar
Clinical Lymphoma Myeloma and Leukemia
2024
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Hodgkin Lymphoma across the United States
Kathryn Lurain , Talal El Zarif , Ramya Ramaswami , Amin Nassar
Blood 142 3071 -3071
2023
Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the cancer therapy using checkpoint inhibitors in people living with HIV-international (CATCH-IT) consortium
Talal El Zarif , Amin H Nassar , Elio Adib , Bailey G Fitzgerald
Journal of Clinical Oncology 41 ( 21) 3712 -3723
15
2023